About pcm

Manuscript Submission

AME Editing Service

Reprint & Permission

Advertising

Contact us

PCM Chinese Edition more

早期三阴性乳腺癌免疫检查点抑制剂回顾

三阴性乳腺癌(triple negative breast... More >>

人类肿瘤中BRAF改变的叙述性综述:诊断和预测意义

B-Raf原癌基因,丝氨酸/苏氨酸激酶( BRAF... More >>

营养影响疾病的潜在分子机制

人体约有50至70万亿个细胞,每个细胞都在高度复杂的生物系统网络中发挥... More >>
Case Report 
Gonadotropin releasing hormone agonist-related meningioma progression causing abducens nerve palsy: an oncological case report
Michael J. McKay, Ritwik Pandey, Hassan Zadeh, Kim Taubman
Precision Cancer Medicine  
2022;
5:
40  
Review Article 
Immune microenvironment and immunotherapy in pancreatic cancer: a narrative review
Xiaoning Yu, Si Shi, Xianjun Yu
Precision Cancer Medicine  
2022;
5:
39  
Review Article 
Applications of generative adversarial networks (GANs) in radiotherapy: narrative review
Zhixiang Wang, Glauco Lorenzut, Zhen Zhang, Andre Dekker, Alberto Traverso
Precision Cancer Medicine  
2022;
5:
37  
Study Protocol 
Protocol: screening of genetic susceptibility genes for breast cancer patients and establishment of genetic high-risk populations cohort in east china communities
Zezhou Wang, Sanjian Yu, Xiaoshuang Feng, Xia Qiu, Hui Ji, Hailin Shan, Qing Shao, Heng Xia, Feng Cao, Jun Li, Cuixia Fu, Liqin Chen, Xiaofang Lu, Tingting Su, Qianqian Yu, Shengqun Hou, Honglian Wang, Yun Liu, Ying Zheng, Zhimin Shao, Zhen Hu
Precision Cancer Medicine  
2022;
5:
36  
Original Article 
Cancer incidence and mortality in Shanghai: rates in 2016 and trends from 2002 to 2016
Chunxiao Wu, Kai Gu, Yi Pang, Pingping Bao, Chunfang Wang, Liang Shi, Yangming Gong, Yongmei Xiang, Jianming Dou, Mengyin Wu, Yan Shi, Chen Fu
Precision Cancer Medicine  
2022;
5:
35  
Expert Consensus 
Chinese expert consensus recommendations for management of bone health in female patients with early breast cancer (2022 edition)
The Society of Breast Cancer of China Anti-Cancer Association, Breast Cancer Study Group Along Yangtze River
Precision Cancer Medicine  
2022;
5:
33  
Editorial 
Introduction to Management of Triple Negative Breast Cancer
Jacques Raphael
Precision Cancer Medicine  
2022;
5:
32  
Editorial 
Neuroimaging aspects and clinical significance of giant perivascular spaces in the brain
Giuseppe Barisano
Precision Cancer Medicine  
2022;
5:
31  
Editorial Commentary 
Uncommon EGFR mutations in non-small-cell lung cancer
Marco Russano, Giuseppe Perrone, Giuseppina Rita Di Fazio, Alessandro Galletti, Fabrizio Citarella, Valentina Santo, Leonardo Brunetti, Alessia Vendittelli, Bruno Vincenzi, Giuseppe Tonini, Daniele Santini
Precision Cancer Medicine  
2022;
5:
30  
Case Report 
Giant perivascular spaces in brain: case report with a comprehensive literature review
Gaurav Cheraya, Suryansh Bajaj, Salil Sharma, Darshan Gandhi, Jignesh Shah, Nisarg Parikh, Nishant Gupta
Precision Cancer Medicine  
2022;
5:
29  
Case Report 
Sporadic mesenteric desmoid-type fibromatosis with “double-hit” T41A and S45P beta-catenin mutation profile: a case report of an extremely rare event—clinically relevant or much ado about nothing?
Saba Shafi, Ashley Patton, Alan Rogers, Valerie Grignol, Steve Oghumu, O. Hans Iwenofu
Precision Cancer Medicine  
2022;
5:
28  
Review Article 
Moving through rare lung cancer histologies: a narrative review on diagnosis and treatment of selected infrequent entities
Chiara Pisano, Gianluca Witel, Marco De Filippis, Angela Listì, Francesca Napoli, Luisella Righi, Silvia Novello, Paolo Bironzo
Precision Cancer Medicine  
2022;
5:
27  
Review Article 
Review: biological implications of oncogenic rearrangements in non-small cell lung cancer
Maria Vittoria Di Marco, Claudia Voena
Precision Cancer Medicine  
2022;
5:
26  
Review Article 
Current state of the art on the diagnosis and the role of target therapy for treatment of ROS1-rearranged non-small cell lung cancer: a narrative review
Francesca Parisi, Giovanni Rossi, Federica Biello, Marco Tagliamento, Giulia Barletta, Lodovica Zullo, Eugenia Cella, Gianluca Sacco, Chiara Dellepiane, Elisa Bennicelli, Diletta Favero, Angela Alama, Simona Coco, Silvia Marconi, Linda Zinoli, Enrica Teresa Tanda, Paolo Pronzato, Erika Rijavec, Carlo Genova
Precision Cancer Medicine  
2022;
5:
25  
Review Article 
Clinical implications of liquid biopsies in urogenital tumors: a narrative review
Laudy Chehade, Ali H. Abdel Sater, Hampig Raphael Kourie, Deborah Mukherji, Ali Shamseddine
Precision Cancer Medicine  
2022;
5:
24  
Review Article 
A narrative review of epidemiology and prevention of lung cancer: sex/gender differences?
Sandra Baldacci, Sara Maio, Claudia Meschi, Davide Chimera, Sofia Tagliaferro, Anna Antonietta Angino, Patrizia Silvi, Francesco Pistelli, Laura Carrozzi
Precision Cancer Medicine  
2022;
5:
23  
Editorial 
Lung cancer in women
Editta Baldini
Precision Cancer Medicine  
2022;
5:
22  
Editorial 
How should clinicians manage metastatic non-small cell lung cancer patients with BRAF non-V600E mutations?
Edyta Maria Urbanska
Precision Cancer Medicine  
2022;
5:
21  

Review Article


Case Report


Editorial

AR-V7 and treatment selection in advanced prostate cancer: are we there yet?
Diogo A. Bastos, Emmanuel S. Antonarakis

Case Report: Precision Oncology Tumor Board

Cases of ROS1-rearranged lung cancer: when to use crizotinib, entrectinib, lorlatinib, and beyond?
Kartik Sehgal, Andrew J. Piper-Vallillo, Hollis Viray, Adeel M. Khan, Deepa Rangachari, Daniel B. Costa